Navitor Pharmaceuticals closes $23.5 mln Series A

Biopharmaceutical company Navitor Pharmaceuticals has closed a $23.5 million Series A financing. Investors include Polaris Partners, Atlas Venture, Johnson & Johnson Development Corporation, SR One and The Longevity Fund. Inc.

North AmericaUSBriefs